Samson, Emma Linda L.
HRN: 16-37-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/10/2023
02/16/2023
IV
4.5g
Q8h
Cellulitis, R Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes